Buscar
Mostrando ítems 1-7 de 7
Effect of ghrelin on glucose-insulin homeostasis: therapeutic implications
(Hindawi, 2010)
[Abstract] Ghrelin is a 28-amino-acid peptide that displays a strong growth hormone- (GH-) releasing activity through the activation of the growth hormone secretagogue receptor (GHSR). The first studies about role of ghrelin ...
The decreased growth hormone response to growth hormone releasing hormone in obesity is associated to cardiometabolic risk factors
(Hindawi, 2010)
[Abstract] The aim of the present study was to evaluate the relationship between GHRH-induced GH secretion in obese premenopausal women and cardiovascular risk markers or insulin resistance. Premenopausal obese women, aged ...
Altered fasting and postprandial plasma ghrelin levels in patients with liver failure are normalized after liver transplantation
(Bioscientifica para European Society for Endocrinology, 2010)
[Abstract]
Context Anorexia is a problem of paramount importance in patients with advanced liver failure. Ghrelin has important actions on feeding and weight homeostasis. Experimental data exist, which suggest that ghrelin ...
Influence of ghrelin and growth hormone deficiency on AMP-activated protein kinase and hypothalamic lipid metabolism
(Wiley, 2010-03-08)
[Abstract] Current evidence demonstrates that the stomach-derived hormone ghrelin, a potent growth hormone (GH) secretagogue, promotes feeding through a mechanism involving the short-term activation of hypothalamic ...
Approved and off-label uses of obesity medications, and potential new pharmacologic treatment options
(MDPI, 2010-01-12)
[Abstract] Available anti-obesity pharmacotherapy options remain very limited and development of more effective drugs has become a priority. The potential strategies to achieve weight loss are to reduce energy intake by ...
Bronchial carcinoid and type 1 multiple endocrine neoplasia syndrome: a case report
(Elsevier, 2010-10)
[Abstract] Carcinoid tumours of bronchial origin are rare in type 1 multiple endocrine neoplasia (MEN1) syndrome. The prevalence of histologically confirmed cases is approximately 5-8%, although in more recent studies it ...